key: cord-0683051-lm33p8yd authors: Qian, Cheng; Lyu, Xiao; Zhu, Hai-Dong; Zhang, Yi; Du, Rui-Jie; Li, Rui; Teng, Gao-Jun; Gu, Jian-Ping title: Venous thromboembolism in non-COVID-19 population during the pandemic: a nationwide multicenter retrospective survey date: 2021-05-14 journal: J Thromb Thrombolysis DOI: 10.1007/s11239-021-02442-2 sha: 9f530715724703a7429bab0fd9d556d924d54904 doc_id: 683051 cord_uid: lm33p8yd Impact of pandemic on the incidence of venous thromboembolism (VTE) in non-COVID-19 patients is undetermined. Thus, a nationwide multicenter retrospective survey was conducted to evaluate the disease burden in non-COVID-19 population. This multi-center survey involved 94 hospitals from 24 provinces in the mainland of China, and collected data on non-COVID-19 patients admitted to the radiology departments due to VTE between January 24 and April 16, 2020. Baseline characteristics, VTE risk factors, clinical manifestations and the treatments were compared with those in the same period of 2019. 3,358 patients with VTE from 74 hospitals were included in this study (1,458 in 2020, 1,900 in 2019). Most aged ≥ 50 years (80.6% in the pandemic, 81.2% in 2019). The number of patients aged 30–39 years increased from 3.9% in 2019 period to 5.8% in the pandemic (p = 0.009). Among the VTE risk factors, the rate of decreased activity increased significantly in the pandemic, and was much higher than that in 2019 (30.7% vs 22.6%, p < 0.0001). Under the risk of decreased activity, patients with comorbidities chronic diseases, especially diabetes, showed significantly a higher incidence of VTE (30.4% vs 22.0%, p < 0.0001). In the pandemic period, fewer patients were treated with anticoagulation alone (33.5% vs 36.7%, p = 0.05), and more underwent inferior vena cava filter (IVCF) implantation, compared with those in 2019 (66.5% vs 63.2%, p = 0.046). The pandemic increased the VTE risk of decreased activity among the non-COVID-19 population. Patients with comorbidities, especially diabetes, have a significant higher risk of VTE during the pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11239-021-02442-2. The coronavirus disease 2019 (COVID-19) is highly contagious and has caused a rapid global pandemic, leading to ten millions infected [1] . Hemostatic abnormalities were reported in patients with COVID-19, such as elevated D-dimer levels (> 1 g/L), prolonged prothrombin time, and increased fibrin degradation (FDP) level [2] . In a multicenter retrospective cohort study, COVID-19 cases with elevated D-dimer levels were reported a highly in-hospital death [3] . In another study, COVID-19 non-survivors showed significantly higher D-dimer and FDP levels [4] . And concomitant venous thromboembolism (VTE), comprising deep vein Cheng Qian, Xiao Lyu and Hai-Dong Zhu contributed equally to this work. thrombosis (DVT) and pulmonary embolism (PE), has been frequently reported in these patients. A study including 81 COVID-19 cases in China, reported 25% developed VTE in intensive care unit [5] . Meanwhile, another study from Netherlands reported that, among 184 patients with severe COVID-19, 31% developed incident VTE (95% CI 20-41) [6] . All the above-mentioned studies focused on patients with COVID-19, and demonstrated that the COVID-19 patients were more likely to have an incident of VTE. However, non-COVID-19 population was far larger than COVID-19 patients. Few attentions have been paid to non-COVID-19 people during the pandemic. The social distancing and self-isolation, and the change of lifestyle, may influence the prevalence of VTE in non-COVID-19 patients. Hence, this nationwide multi-center investigation was conducted on non-COVID-19 patients admitted to the radiology departments in China and designed to evaluate the prevalence, the characterize clinical presentation and the potential risk factors for VTE in non-COVID-19 patients. This multi-center survey involving 94 radiology departments from 24 provinces in the mainland of China, was conducted between January 24 and April 16, 2020 (from the locking down of Wuhan to work resumption in most cities across China). This survey was approved by each institutional review board. Non-COVID-19 patients admitted to the radiology departments due to VTE were enrolled. Baseline characteristics (age, sex, and comorbidities disease), VTE risk factors, and clinical manifestations were collected by a questionnaire (Supplemental table) . Except for age, all other questions have been presented in the form of multiple-choice questions. Possible VTE risk factors include decreased activity (greater time spent sitting or lying down, and physical activity time less than half of the usual ≥ 3 days, with no other disease reasons), recent surgery performed in the prior 2 months (including abdominal, cardiac, neurological surgery, etc.), traumatic fractures without surgery in the prior one month, immobilization for at least one week for any nonsurgical reason in the prior one month and others (including hormonal therapy, fat and chronic lung disease) [7, 8] . The categories of VTE including DVT and PE were analyzed. The treatments were also evaluated, including anticoagulation alone, inferior vena cava filter (IVCF) implantation, and additional interventional radiology therapy (including catheter-directed thrombolysis, percutaneous mechanical thrombectomy, balloon dilatation, or stent implantation). Data were compared with those of the in-hospital VTE patients during the same period in 2019 (from January 24 to April 16). Finally, three senior doctors gathered and analyzed all the data. Individual data were summarized as frequencies or percentages for categorical variables and median (interquartile range) for continuous variables. The Chi-square test was used to compare categorical variables. Student's t-test was used to compare continuous variables. The differences were considered statistically significant at p ≤ 0.05 (two-tailed). All statistical analyses were performed using SPSS software (version 22). Among the 94 hospitals, four had no data in the pandemic period, sixteen did not provide the data of the same period in 2019, and three cases were with COVID-19. Finally, a total of 3,358 patients from 74 hospitals across the mainland China were included in this study (Fig. 1 ). During the pandemic period (between January 24 and April 16, 2020), 1,458 non-COVID-19 patients were diagnosed with VTE, with 745 males (51.1%), the median age was 64 years. During the same period in 2019, 1,900 patients were diagnosed with VTE, with 915 males (48.2%), the median age was 64 years. No statistical differences were observed between the two groups (p > 0.05) ( Table 1) . In both groups, the rate of VTE increased with aging and reached a peak at the age of 60-69 years. The incidence of VTE was mostly in the patients aged ≥ 50 years, 80.6% in the pandemic period, and 81.2% in the same period of 2019. In the pandemic period, more patients aged 30-39 years had an incident VTE than those in 2019 period (5.8% vs 3.9%, p = 0.009) (Fig. 2 ). During the pandemic period, a total of 724 patients (49.7%) were with chronic comorbidities, and 334 (23.6%) with more than two kinds of comorbidities. The most common diseases were hypertension (34.0%), diabetes (18.2%), coronary artery disease (12.2%) and stroke (11.5%) in the pandemic period. Others were 11.8%, including chronic obstructive pulmonary disease, chronic kidney disease, etc. During the same period in 2019, hypertension (34.7%), diabetes (15.4%), stroke (10.5%) and coronary artery disease (10.3%) remained the most common comorbidities. Patients with diabetes showed significantly a higher incidence of VTE during the pandemic period than those in the same period of 2019 (18.2% vs 15.4%, p < 0.001) ( Table 1) . Among the potential risk factors of VTE, decreased activity was the first factor in the pandemic period, and the rate was significantly higher than that in the same period of 2019 (30.7% vs 22.6%, p < 0.0001). Patients with more than two risk factors showed significantly a higher incidence of VTE than those in 2019 (5.6% vs 4.1%, p = 0.041). Under the risk of decreased activity, patients with comorbidities chronic diseases showed more likely to have an incident VTE than those without comorbidities chronic diseases (30.4% vs 22.0%, p < 0.0001). However, the incidence rate of VTE due to trauma decreased from 13.1% in 2019 period to 11.5% in pandemic period, and the incidence rate of VTE induced by surgery was also lower during the pandemic period (8.4% vs 11.3%, p = 0.007). The remaining risk factors such as active cancer, immobilization, previous VTE, and so on showed no significant differences between the two groups (p > 0.05) ( Table 1) . The clinical manifestations such as syncope, stuffiness, swelling, lower limb pain, or tenderness showed no significant differences between the two groups. Most patients admitted to the hospitals with limb symptoms alone, 89% in the pandemic period and 88% in the same period of 2019. In the pandemic period, 1,142 (78.3%) patients with DVT alone, 26 (1.8%) with PE alone, and 290 (19.9%) with PE and DVT, versus 1,494 (78.6%), 40 (2.1%) and 366 (19.3%) in the same period of 2019, respectively. No statistical differences were observed between the two groups. The total rate of incidence PE was 21.7% in the pandemic period, versus 21.4% in the same period of 2019. And the rate of symptomatic PE was also similar between the groups (43.4% vs 48.0%, p > 0.05). The number of patients treated with anticoagulation alone during the pandemic period was fewer than that in 2019 (33.5% vs 36.7%, p = 0.05). And more patients accepted IVCF implantation in the pandemic period (66.5% vs 63.2%, p = 0.046). The rate of additional interventional therapy also increased from 41.9% to 44.1% in the pandemic period. The short-outcome on discharge showed no difference between two groups ( Table 2) . This is a nationwide survey to provide insights into the disease burden of VTE in the non-COVID-19 population. Among the VTE patients without COVID-19, 80.6% aged ≥ 50 years during the pandemic. Population-based studies reported that the incidence of VTE rises exponentially with age, and > 60% VTE events occur in persons aged ≥ 65 years [9, 10] . Those patients have higher mortality and VTErelated morbidity than younger patients, including anticoagulation-related bleeding and the post-thrombotic syndrome [11] . Therefore, special attention should be paid to elder non-COVID-19 patients during the pandemic. As the world is entering into increasingly unprecedented territory with lockdowns and social-distancing orders, non-COVID-19 patients are asked to self-isolation [12] . Many people spent more time sitting or lying down at home, and their physical activity time was less than half of the usual [13] . The present study showed that decreased activity was the first risk factor in the pandemic period, with significantly higher rate than that in the same period of 2019. Decreased activity reduces venous blood flow, particularly in the pockets of the venous valves, resulting in stasis and increased coagulation [14] . It also increases the possibility of prethrombotic state when the duration is more than 24 h, it will be a risk factor if the duration exceeds 3 days [15] . In previous studies, decreased activity has been identified as the main factor of hospital-acquired VTE [16] . Data from the RIETE registry trial reported that recent decreased activity provoke the recurrence of VTE and PE in COPD patients with VTE, the OR are 0.96 (0.61-1.53) and 1.01 (0.57-1.79) respectively [15] . Therefore, this study recommended appropriate activity to reduce the possibility of VTE during the self-isolation. On the other hand, decreased activity reduced the risk of trauma and surgery in turn. Thus, the pandemic also affected the constituent ratio of the VTE risk factors. Under the risk of decreased activity, patients with chronic comorbidities disease, especially diabetes, showed a higher incident VTE rate. The linking between diabetes and VTE has been proven in some studies. It has been reported that many clotting factors are elevated in diabetes mellitus [17] . And a comprehensive meta-analysis also suggested that diabetes was associated with increased risk of VTE [18] . Therefore, patients with chronic comorbidities disease should be aware of incident VTE during the pandemic.During the pandemic, home-based exercise can be beneficial for older adults [19, 20] . Behnood Bikdeli et al. recommended the Table 1 Baseline characteristics of patients with venous thromboembolism in the pandemic period and in the same period of 2019 IQR interquartile range, VTE venous thromboembolism a Decreased activity (greater time spent sitting or lying down, and physical activity time less than half of the usual ≥ 3 days) b Recent trauma without surgery c Recent surgery performed in the prior 2 months (including trauma, abdominal, genitourinary, orthopedic, cardiac, vascular, or neurological surgery) d Immobilization for at least 7 days for any non-surgical reason in the prior one month (associated or not with medical conditions, or non-operable fractures) e Other risk factors including hormonal therapy, fat and chronic lung disease patients without COVID-19 but with risk factors to increase mobility, and even administer pharmacologic prophylaxis after risk assessment. Telemedicine and e-visits were preferable to minimize the risks of in-person interactions between healthcare worker and patient [2] . Under the panic of COVID-19, it showed that patients were more likely to choose aggressive treatment. The rate of IVCF implantation and additional interventional therapy increased in the pandemic period. And only 33.5% patients were treated with anticoagulation alone in the pandemic period, which was lower than that in 2019. The findings in this study have some crucial implications for health-care resource planning and preventive strategies. To our knowledge, it is the largest study to date that examined how the pandemic affects the prevalence of VTE in patients without COVID-19 in China. The study has some limitations. First, because of its retrospective nature and limitation of the data available (derived predominantly from the radiology departments), and those with VTE did not go to the hospitals were not included, a potential exists for misrepresentation of national hospitalizations may exist. Second, lack of information (duration, severity, follow-up, etc.) limited further evaluation. Third, the pandemic period (from January 24th to April 16th) was not divided into different stages reported by other studies [21, 22] . Even so, we tried to send an important message as Dr. Rosenbaum called for, "Covid or no Covid, we are still here to care for you" [23] . Promoting healthy living for future pandemic protection should be considered [24] . This study provides insights into the disease burden of VTE in non-COVID-19 population in China. The pandemic increased the VTE risk in patients with decreased activity among the non-COVID-19 population. Patients with comorbidities, especially diabetes, have a significant higher risk of VTE during the pandemic. Therefore, we would like to call for attentions to non-COVID-19 people during the pandemic. The online version contains supplementary material available at https:// doi. org/ 10. 1007/ s11239-021-02442-2. Fig. 2 Proportion of the patients with venous thromboembolism (VTE) in each age range. *p < 0.05. Patients aged 30-39 years showed a higher VTE rate (5.8%) in the pandemic period than that in 2019 period (3.9%) 3) 1494 (78.6) Only PE, n (%) 26 (1.8) 40 (2.1) DVT and PE, n (%) 290 (19.9) 366 (19.3) Treatment Anticoagulation alone Unremission, n (%) Yanan Hospital of Kunming City) Nanjing General Hospital of the Nanjing Military Command) Shuyang People's Hospital) Xiangya Hospital Wuxi Third People's Hospital) The First Affiliated Hospital of Sun Yat-sen University) The Affiliated Huai'an No.1 People's Hospital) Guangzhou Women and Children's Medical Centre) The First Hospital of Putian City) The Second Affiliated Hospital of Qujing First People's Hospital) Lei Yu (the People's Hospital of Guangxi Zhuang Autonomous Region) Zhuhai People's Hospital) The Second Affiliated Hospital of Tenth People's Hospital of Tongji University) Gansu Provincial Hospital) Mugen Zhang (the 92nd Hospital of Chinese PLA) Penghua Lv (Northern Jiangsu People's Hospital) Sichuan Provincial People's Hospital) Po Yang (the Fourth Affiliated Hospital of The Affiliated Hospital of Shiwu Yin (The Second People's Hospital of Hefei) The First Affiliated Hospital of Shandong First Medical University) The Fourth Hospital of Changsha City the Fourth Hospital of Changsha) The First Affiliated Hospital of Wuxi First People's Hospital) Jiangyin People's Hospital) Xiaofei Sun (The Mineral General Hospital of Xuzhou) Xiaoli Zhu Xiaoming Chen (Guangdong Provincial People's Hospital) Xindong Fan (Shanghai Ninth People's Hospital) Second People's Hospital of Gansu Province) Wenzhou People's Hospital) Xudong Chen (Shenzhen People's Hospital) The Affiliated Cancer Hospital of Affiliated Union Hospital of The Tibet Autonomous Region People's Hospital) Affiliated Tumor Hospital of Shengjing Hospital of Yancheng Third People's Hospital) Zhuting Fang (Fujian Provincial Hospital) General Projects): NMUB2019144. References 1. Organization WH Coronavirus Disease 2019 (COVID-19) situation report-59 COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Venous thromboembolism risk and postpartum lying-in: acculturation of Indian and Chinese women Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study Venous thromboembolism in the elderly a community-based perspective Incidence and mortality of venous thrombosis: a population-based study Venous thromboembolism in the elderly: a narrative review Social, ethical and behavioural aspects of COVID-19 Evolution of changes in physical activity over lockdown time: physical activity datasets of four independent adult sample groups corresponding to each of the last four of the six COVID-19 lockdown weeks in Greece The contribution of immobility risk factors to the incidence of venous thrombosis in an older population The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease A systematic review of mobility/immobility in thromboembolism risk assessment models for hospitalized patients Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis Home-based exercise can be beneficial for counteracting sedentary behavior and physical inactivity during the COVID-19 pandemic in older adults Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: special focus in older people Emergency responses to Covid-19 outbreak: experiences and lessons from a general hospital in Nanjing, China COVID-19: what should interventional radiologists know and what can they do? The untold toll-the pandemic's effects on patients without Covid-19 The global path forward-Healthy Living for Pandemic Event Protection (HL -PIVOT) Conflict of interest All authors declare that they have no conflict of interest.